Natalie Sacks - 11 Nov 2021 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Chief Medical Officer
Signature
/s/ Natalie Sacks by Georgia Erbez, Attorney-in-Fact
Issuer symbol
HARP
Transactions as of
11 Nov 2021
Transactions value $
$0
Form type
4
Filing time
15 Nov 2021, 15:03:19 UTC
Previous filing
22 Jul 2021
Next filing
21 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Employee Stock Option (right to buy) Award $0 +155,000 $0 155,000 11 Nov 2021 Common Stock 155,000 $7.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fifty percent of the stock option shall be fully vested and exercisable on the first anniversary of the vesting commencement date, November 11, 2022, and thereafter twenty-five percent of the stock option shall vest on each May 11, 2023, and November 11, 2023.